Gilead's Oral Drug Eliminated Symptoms in Mid-Stage IBD Trial
⏮ BeforePatients with this type of inflammatory bowel disease have symptoms that persist under current options.
✅ NowIn a mid-stage study, an oral Gilead treatment eliminated those symptoms, still in trials.
In short
- Gilead Sciences' oral treatment eliminated symptoms for patients with a type of inflammatory bowel disease.
- Results from a mid-stage study were reported on Monday.
- The drug is still in trials and has not yet been approved for patients.
Why the Good News Desk likes this one
Inflammatory bowel disease can cause long-running symptoms that affect daily life. A pill that clears symptoms in a mid-stage study is an early but meaningful signal. Larger trials are needed before patients can know whether it will work for them.
Advertisement
From STAT
An oral treatment from Gilead Sciences eliminated the symptoms experienced by patients with a type of inflammatory bowel disease, according to mid-stage study results reported Monday.
Ask this story
Next in today's ten
Advertisement